Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;27(1):17-23.
doi: 10.1007/s10286-016-0389-z. Epub 2016 Nov 12.

Acute cyclooxygenase inhibition and baroreflex sensitivity in lean and obese adults

Abdulrahman A Al-Khateeb  1   2 , Jacqueline K Limberg  1 , Jill N Barnes  1 , Michael J Joyner  1 , Nisha Charkoudian  3 , Timothy B Curry  4
Affiliations

Acute cyclooxygenase inhibition and baroreflex sensitivity in lean and obese adults

Abdulrahman A Al-Khateeb et al. Clin Auton Res. 2017 Feb.

Abstract

Purpose: Obese adults exhibit increased levels of inflammation, which may negatively affect blood pressure regulation. Based on existing literature, we hypothesized: (1) baroreflex sensitivity would be lower in obese adults when compared to lean adults; (2) acute ibuprofen (IBU, a cyclooxygenase inhibitor and nonsteroidal antiinflammatory agent) administration would increase baroreflex sensitivity in obese adults, with no effect in lean adults.

Methods: Seven lean (4 male, 3 female) and six obese (5 M, 1 F) adults completed two visits randomized to control (CON) or IBU (800 mg oral). On each visit, blood pressure (intra-arterial catheter), heart rate (ECG), and muscle sympathetic nerve activity (MSNA, microneurography) were measured continuously. Sympathetic and cardiac baroreflex sensitivities were assessed using the modified Oxford technique.

Results: Measures of systemic inflammation [C-reactive protein (CRP) and interleukin-6 (IL-6)] were higher in obese adults when compared to lean adults and tended to decrease with IBU (IL-6: p < 0.05; CRP: p = 0.14). Cardiac baroreflex sensitivity was lower in obese adults (14 ± 2 vs. 24 ± 2 ms/mmHg, p = 0.02), whereas sympathetic baroreflex sensitivity was higher in obese adults (-3.6 ± 0.5 vs. -2.1 ± 0.5 bursts/100 beats/mmHg, p = 0.03) when compared to lean. There was no effect of IBU on cardiac or sympathetic baroreflex sensitivity in either group (p value range 0.20-0.71).

Conclusion: Despite obese individuals exhibiting higher levels of systemic inflammation and lower cardiac baroreflex sensitivity when compared to lean adults, an acute dose of IBU has no effect on cardiac or sympathetic baroreflex sensitivity.

Keywords: Autonomic nervous system; Cardiovagal; Ibuprofen; Inflammation; Sympathetic.

PubMed Disclaimer

Conflict of interest statement

ADDITIONAL INFORMATION Competing Interests: There are no competing interests and no relevant conflicts of interest.

References

    1. Fanciulli A, Gobel G, Ndayisaba JP, Granata R, Duerr S, Strano S, Colosimo C, Poewe W, Pontieri FE, Wenning GK (2016) Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res 26:97–105 - PubMed
    1. Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, Biaggioni I, Robertson D. Renal impairment of pure autonomic failure. Hypertension. 2009;54:1057–1061. doi: 10.1161/HYPERTENSIONAHA.109.136853. - DOI - PMC - PubMed
    1. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. doi:10.1007/s00415-016-8375-x - PMC - PubMed
    1. Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res: Off J Clin Auton Res Soc. 2016;26:15–21. doi: 10.1007/s10286-015-0324-8. - DOI - PubMed
    1. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet. 2000;355:725–726. doi: 10.1016/S0140-6736(99)05320-9. - DOI - PubMed

Publication types